Assigning new roles to topical tacrolimus

Bibliography

• CARROLL CL, FLEISCHER AB Jr: Tacrolimus ointment: the treatment of atopic dermatitis and other inflammatory cutaneous disease. Expert Opin. Pharmacother. (2004) 5(10):2127-2137.
   PubMed Web of Science ®Google Scholar
• WOLLENBERG A, SHARMA S, VON BUBNOFF D, GEIGER E, HABERSTOK J, BIEBER T: Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis. J. Allergy Clin. Immunol. (2001) 107(3):519-525.
   PubMed Web of Science ®Google Scholar
• INOUE T, KATOH N, KISHIMOTO S: Prolonged topical application of tacrolimus inhibits immediate hypersensitivity reactions by reducing degranulation of mast cells. Acta Derm. Venereol. (2006) 86(1):13-16.
   PubMed Web of Science ®Google Scholar
• BELSITO D, WILSON DC, WARSHAW E et al.: A prospective randomized clinical trial of 0.1% tacrolimus ointment in a model of chronic allergic contact dermatitis. J. Am. Acad. Dermatol. (2006) 55(1):40-46.
   PubMed Web of Science ®Google Scholar
• ALOMAR A, PUIG L, GALLARDO CM, VALENZUELA N: Topical tacrolimus 0.1% ointment (protopic) reverses nickel contact dermatitis elicited by allergen challenge to a similar degree to mometasone furoate 0.1% with greater suppression of late erythema. Contact Dermatitis (2003) 49(4):185-188.
   PubMed Web of Science ®Google Scholar
• SARIPALLI YV, GADZIA JE, BELSITO DV: Tacrolimus ointment 0.1% in the treatment of nickel-induced allergic contact dermatitis. J. Am. Acad. Dermatol. (2003) 49(3):477-482.
   PubMed Web of Science ®Google Scholar
• BÄUMER W, SÜLZLE B, WEIGT H et al.: Cilomilast, tacrolimus and rapamycin modulate dendritic cell function in the elicitation phase of allergic contact dermatitis. Br. J. Dermatol. (2005) 153:136-144.
   PubMed Web of Science ®Google Scholar
• LAUERMA AI, STEIN BD, HOMEY B, LEE CH, BLOOM E, MAIBACH HI: Topical FK506: suppression of allergic and irritant contact dermatitis in the guinea pig. Arch. Dermatol. Res. (1994) 286:337-340.
   PubMed Web of Science ®Google Scholar
• SCHNOPP C, REMLING R, MOHRENSCHLAGER M, WEIGL L, RING J, ABECK D: Topical tacrolimus (FK506) and mometasone furoate in treatment of dyshidrotic palmar eczema: a randomized, observer-blinded trial. J. Am. Acad. Dermatol. (2002) 46(1):73-77.
   PubMed Web of Science ®Google Scholar
• THELMO MC, LANG W, BROOKE E et al.: An open-label pilot study to evaluate the safety and efficacy of topically applied tacrolimus ointment for the treatment of hand and/or foot eczema. J. Dermatolog. Treat. (2003) 14(3):136-140.
   PubMedGoogle Scholar
• MESHKINPOUR A, SUN J, WEINSTEIN G: An open pilot study using tacrolimus ointment in the treatment of seborrheic dermatitis. J. Am. Acad. Dermatol. (2003) 49(1):145-147.
   PubMed Web of Science ®Google Scholar
• BRAZA TJ, DiCARLO JB, SOON SL, McCALL CO: Tacrolimus 0.1% ointment for seborrhoeic dermatitis: an open-label pilot study. Br. J. Dermatol. (2003) 148(6):1242-1244.
   PubMed Web of Science ®Google Scholar
• UETSU N, OKAMOTO H, FUJII K, DOI R, HORIO T: Treatment of chronic actinic dermatitis with tacrolimus ointment. J. Am. Acad. Dermatol. (2002) 47(6):881-884.
   PubMed Web of Science ®Google Scholar
• EDMONDS EV, RIAZ SN, FRANCIS N, BUNKER CB: Nodular prurigo responding to topical tacrolimus. Br. J. Dermatol. (2004) 150(6):1216-1217.
   PubMed Web of Science ®Google Scholar
• DISSEMOND J, KNAB J, LEHNEN M, FRANCKSON T, GOOS M: Successful treatment of stasis dermatitis with topical tacrolimus. VASA (2004) 33(4):260-262.
   PubMed Web of Science ®Google Scholar
• ZONNEVELD IM, RUBINS A, JABLONSKA S et al.: Topical tacrolimus is not effective in chronic plaque psoriasis. A pilot study. Arch. Dermatol. (1998) 134(11):1386.
   Web of Science ®Google Scholar
• REMITZ A, REITAMO S, ERKKO P, GRANLUND H, LAUERMA AI: Tacrolimus ointment improves psoriasis in a microplaque assay. Br. J. Dermatol. (1999) 141(1):103-107.
   Web of Science ®Google Scholar
• CARROLL CL, CLARKE J, CAMACHO F, BALKRISHNAN R, FELDMAN SR: Topical tacrolimus ointment combined with 6% salicylic acid gel for plaque psoriasis treatment. Arch. Dermatol. (2005) 141(1):43-46.
   PubMed Web of Science ®Google Scholar
• ORTONNE JP, VAN DE KERKHOF PC, PRINZ JC et al.: 0.3% Tacrolimus gel and 0.5% tacrolimus cream show efficacy in mild to moderate plaque psoriasis: results of a randomized, open-label, observer-blinded study. Acta Derm. Venereol. (2006) 86(1):29-33.
   PubMed Web of Science ®Google Scholar
• RIVARD J, JANIGA J, LIM HW: Tacrolimus ointment 0.1% alone and in combination with medium-dose UVA1 in the treatment of palmar or plantar psoriasis. J. Drugs Dermatol. (2006) 5(6):505-510.
   PubMedGoogle Scholar
• LEBWOHL M, FREEMAN AK, CHAPMAN MS, FELDMAN SR, HARTLE JE, HENNING A: Tacrolimus ointment is effective for facial and intertriginous psoriasis. J. Am. Acad. Dermatol. (2004) 51(5):723-730.
   PubMed Web of Science ®Google Scholar
• RALLIS E, NASIOPOULOU A, KOUSKOUKIS C et al.: Successful treatment of genital and facial psoriasis with tacrolimus ointment 0.1%. Drugs Exp. Clin. Res. (2005) 31(4):141-145.
   PubMedGoogle Scholar
• STEELE JA, CHOI C, KWONG PC: Topical tacrolimus in the treatment of inverse psoriasis in children. J. Am. Acad. Dermatol. (2005) 53(4):713-716.
   PubMed Web of Science ®Google Scholar
• WILSMANN-THEIS D, HAGEMANN T, DEDERER H, WENZEL J, BIEBER T, NOVAK N: Successful treatment of acrodermatitis continua suppurativa with topical tacrolimus 0.1% ointment. Br. J. Dermatol. (2004) 150(6):1194-1197.
   PubMed Web of Science ®Google Scholar
• NAGAO K, ISHIKO A, YOKOYAMA T, TANIKAWA A, AMAGAI M: A case of generalized pustular psoriasis treated with topical tacrolimus. Arch. Dermatol. (2003) 139(9):1219.
   PubMedGoogle Scholar
• LAEIJENDECKER R, TANK B, DEKKER SK, NEUMANN HA: A comparison of treatment of oral lichen planus with topical tacrolimus and triamcinolone acetonide ointment. Acta Derm. Venereol. (2006) 86(3):227-229.
   PubMed Web of Science ®Google Scholar
• BYRD JA, DAVIS MD, BRUCE AJ, DRAGE LA, ROGERS RS III : Response of oral lichen planus to topical tacrolimus in 37 patients. Arch. Dermatol. (2004) 140(12):1508-1512.
   PubMed Web of Science ®Google Scholar
• BYRD JA, DAVIS MD, ROGERS RS III: Recalcitrant symptomatic vulvar lichen planus: response to topical tacrolimus. Arch. Dermatol. (2004) 140(6):715-720.
   PubMed Web of Science ®Google Scholar
• DOMINGUEZ MV, MATEU AV, VIEIRA R, SOLANO JL, SINTES RN, SALMERON MT: Linear lichen planus and hepatitis C. Dermatol. Online J. (2006) 12(2):17.
   PubMedGoogle Scholar
• HENGGE UR, KRAUSE W, HOFMANN H: Multicentre, Phase II trial on the safety and efficacy of topical tacrolimus ointment for the treatment of lichen sclerosus. Br. J. Dermatol. (2006) 155(5):1021-1028.
   PubMed Web of Science ®Google Scholar
• DOBBS CR, MURPHY SJ: Lichen nitidus treated with topical tacrolimus. J. Drugs Dermatol. (2004) 3(6):683-684.
   PubMedGoogle Scholar
• FUJIMOTO N, TAJIMA S, ISHIBASHI A: Facial lichen striatus: successful treatment with tacrolimus ointment. Br. J. Dermatol. (2003) 148(3):587-590.
   PubMed Web of Science ®Google Scholar
• LEPE V, MONCADA B, CASTANEDO-CAZARES JP, TORRES-ALVAREZ MB, ORTIZ CA, TORRES-RUBALCAVA AB: A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo. Arch. Dermatol. (2003) 139(5):581-585.
   PubMed Web of Science ®Google Scholar
• SILVERBERG NB, LIN P, TRAVIS L et al.: Tacrolimus ointment promotes repigmentation of vitiligo in children: a review of 57 cases. J. Am. Acad. Dermatol. (2004) 51(5):760-766.
   PubMed Web of Science ®Google Scholar
• OSTOVARI N, PASSERON T, LACOUR JP, ORTONNE JP: Lack of efficacy of tacrolimus in the treatment of vitiligo in the absence of UV-B exposure. Arch. Dermatol. (2006) 142(2):252-253.
   PubMed Web of Science ®Google Scholar
• MEHRABI D, PANDYA AG: A randomized, placebo-controlled, double-blind trial comparing narrowband UV-B plus 0.1% tacrolimus ointment with narrowband UV-B plus placebo in the treatment of generalized vitiligo. Arch. Dermatol. (2006) 142(7):927-929.
   PubMed Web of Science ®Google Scholar
• PASSERON T, OSTOVARI N, ZAKARIA W et al.: Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo. Arch. Dermatol. (2004) 140(9):1065-1069.
   PubMed Web of Science ®Google Scholar
• GACH JE, ILCHYSHYN A: Beneficial effects of topical tacrolimus on recalcitrant erosions of pemphigus vulgaris. Clin. Exp. Dermatol. (2004) 29(3):271-271.
   Web of Science ®Google Scholar
• COHEN SN, LIM RP, PAUL CJ, ABDULLAH A: Equal efficacy of topical tacrolimus and clobetasone butyrate in pemphigus foliaceus. Int. J. Dermatol. (2006) 45(11):1379.
   PubMed Web of Science ®Google Scholar
• KO MJ, CHU CY: Topical tacrolimus therapy for localized bullous pemphigoid. Br. J. Dermatol. (2003) 149(5):1079-1081.
   PubMed Web of Science ®Google Scholar
• VECCHIETTI G, KERL K, HUGLI A, SAMSON J, BORRADORI L: Topical tacrolimus (FK506) for relapsing erosive stomatitis in paraneoplastic pemphigus. Br. J. Dermatol. (2003) 148(4):833-834.
   PubMed Web of Science ®Google Scholar
• SAND C, THOMSEN HK: Topical tacrolimus ointment is an effective therapy for Hailey-Hailey disease. Arch. Dermatol. (2003) 139(11):1401-1402.
   PubMed Web of Science ®Google Scholar
• CARROLL PB, RILO HL, ABU ELMAGD K et al.: Effect of tacrolimus (FK506) in dystrophic epidermolysis bullosa: rationale and preliminary results. Arch. Dermatol. (1994) 130(11):1457-1458.
   PubMed Web of Science ®Google Scholar
• PARK SW, KIM JW, WANG HY: Topical tacrolimus (FK506): treatment failure in four cases of alopecia universalis. Acta Derm. Venereol. (2002) 82(5):387-388.
   PubMed Web of Science ®Google Scholar
• PRICE VH, WILLEY A, CHEN BK: Topical tacrolimus in alopecia areata. J. Am. Acad. Dermatol. (2005) 52(1):138-139.
   PubMed Web of Science ®Google Scholar
• FREYSCHMIDT-PAUL P, ZIEGLER A, McELWEE KJ et al.: Treatment of alopecia areata in C3H/HeJ mice with the topical immunosuppressant FK506 (tacrolimus). Eur. J. Dermatol. (2001) 11(5):405-409.
   PubMed Web of Science ®Google Scholar
• CLARK-LOESER L, LATKOWSKI JA: Frontal fibrosing alopecia. Dermatol. Online J. (2005) 11(4):6.
   PubMedGoogle Scholar
• LAFFITE E, KAYA G, PIGUET V, SAURAT JH: Erosive pustular dermatosis of the scalp: treatment with topical tacrolimus. Arch. Dermatol. (2003) 139(6):712-714.
   PubMed Web of Science ®Google Scholar
• BAMFORD JT, ELLIOTT BA, HALLER IV: Tacrolimus effect on rosacea. J. Am. Acad. Dermatol. (2004) 50(1):107-108.
   PubMed Web of Science ®Google Scholar
• GOLDMAN D: Tacrolimus ointment for the treatment of steroid-induced rosacea: a preliminary report. J. Am. Acad. Dermatol. (2001) 44(6):995-998.
   PubMed Web of Science ®Google Scholar
• MISAGO N, NAKAFUSA J, NARISAWA Y: Childhood granulomatous periorificial dermatitis: lupus miliaris disseminatus faciei in children? J. Eur. Acad. Dermatol. Venereol. (2005) 19(4):470-473.
   PubMed Web of Science ®Google Scholar
• KATOH N, MIHARA H, YASUNO H: Cutaneous sarcoidosis successfully treated with topical tacrolimus. Br. J. Dermatol. (2002) 147(1):154-156.
   PubMed Web of Science ®Google Scholar
• JAIN S, STEPHENS CJ: Successful treatment of disseminated granuloma annulare with topical tacrolimus. Br. J. Dermatol. (2004) 150(5):1042-1043.
   PubMed Web of Science ®Google Scholar
• HARTH W, LINSE R: Topical tacrolimus in granuloma annulare and necrobiosis lipoidica. Br. J. Dermatol. (2004) 150(4):792-794.
   PubMed Web of Science ®Google Scholar
• MARCOVAL J, MORENO A, BORDAS X, PEYRI J: Granuloma faciale: treatment with topical tacrolimus. J. Am. Acad. Dermatol. (2006) 55(5 Suppl.):S110-S111.
   PubMed Web of Science ®Google Scholar
• SNIEZEK PJ, KRISTJANSSON A, STONE MS: Annular atrophic plaques on the arms of a 57-year-old woman. Arch. Dermatol. (2006) 142(6):775-780.
   PubMedGoogle Scholar
• CLAYTON TH, HARRISON PV: Successful treatment of chronic ulcerated necrobiosis lipoidica with 0.1% topical tacrolimus ointment. Br. J. Dermatol. (2005) 152(3):581-582.
   PubMed Web of Science ®Google Scholar
• KONTOS AP, KERR HA, FIVENSON DP, REMISHOFSKY C, JACOBSEN G: An open-label study of topical tacrolimus ointment 0.1% under occlusion for the treatment of pyoderma gangrenosum. Int. J. Dermatol. (2006) 45(11):1383-1385.
   PubMed Web of Science ®Google Scholar
• LYON CC, STAPLETON M, SMITH AJ, MENDELSOHN S, BECK MH, GRIFFITHS CE: Topical tacrolimus in the management of peristomal pyoderma gangrenosum. J. Dermatolog. Treat. (2001) 12(1):13-17.
   PubMed Web of Science ®Google Scholar
• MACKELFRESH J, SOON S, ARBISER JL: Combination therapy of doxycycline and topical tacrolimus for venous ulcers. Arch. Dermatol. (2005) 141(11):1476-1477.
   PubMed Web of Science ®Google Scholar
• TZUNG TY, LIU YS, CHANG HW: Tacrolimus vs. clobetasol propionate in the treatment of facial cutaneous lupus erythematosus: a randomized, double-blind, bilateral comparison study. Br. J. Dermatol. (2007) 156(1):191-192.
   PubMed Web of Science ®Google Scholar
• LAMPROPOULOS CE, SANGLE S, HARRISON P, HUGHES GR, D'CRUZ DP: Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative. Rheumatology (Oxford) (2004) 43(11):1383-1385.
   PubMed Web of Science ®Google Scholar
• HOLLAR CB, JORIZZO JL: Topical tacrolimus 0.1% ointment for refractory skin disease in dermatomyositis: a pilot study. J. Dermatolog. Treat. (2004) 15(1):35-39.
   PubMedGoogle Scholar
• MANCUSO G, BERDONDINI RM: Localized scleroderma: response to occlusive treatment with tacrolimus ointment. Br. J. Dermatol. (2005) 152(1):180-182.
   PubMed Web of Science ®Google Scholar
• YOKOTA K, SHICHINOHE R, HAYASAKA T: Topical tacrolimus in the treatment of annular erythema associated with Sjögren's syndrome. Clin. Exp. Dermatol. (2005) 30(4):450-451.
   PubMed Web of Science ®Google Scholar
• MOODY BR, SENGELMANN RD: Topical tacrolimus in the treatment of bovine collagen hypersensitivity. Dermatol. Surg. (2001) 27(9):789-791.
   PubMed Web of Science ®Google Scholar
• YUZAWA K, TANIGUCHI H, SEINO K, OTSUKA M, FUKAO K: Topical immunosuppression in skin grafting with FK 506 ointment. Transplant. Proc. (1996) 28(3):1387-1389.
   PubMed Web of Science ®Google Scholar
• MALLIPEDDI R, EVANS AV: Refractory pityriasis lichenoides chronica successfully treated with topical tacrolimus. Clin. Exp. Dermatol. (2003) 28(4):456-458.
   PubMed Web of Science ®Google Scholar
• SIMON D, BOUDNY C, NIEVERGELT H, SIMON HU, BRAATHEN LR: Successful treatment of pityriasis lichenoides with topical tacrolimus. Br. J. Dermatol. (2004) 150(5):1033-1035.
   PubMed Web of Science ®Google Scholar
• WHITE KL: Pityriasis rubra pilaris. Dermatol. Online J. (2003) 9(4):6.
   PubMedGoogle Scholar
• RALLIS E, ECONOMIDI A, VERROS C, PAPADAKIS P: Successful treatment of patch type mycosis fungoides with tacrolimus ointment 0.1%. J. Drugs Dermatol. (2006) 5(9):906-907.
   PubMedGoogle Scholar
• SANTOS-JUANES J, SANCHEZ DEL RIO J, GALACHE C, SOTO J: Topical tacrolimus: an effective therapy for Zoon balanitis. Arch. Dermatol. (2004) 140(12):1538-1539.
   PubMed Web of Science ®Google Scholar
• CASTANEDO-CAZARES JP, LEPE V, MONCADA B: Lichen amyloidosis improved by 0.1% topical tacrolimus. Dermatology (2002) 205(4):420-421.
   PubMed Web of Science ®Google Scholar
• KAWAGUCHI M, MITSUHASHI Y, KONDO S: Successful treatment of eosinophilic pustular folliculitis with topical tacrolimus. Int. J. Dermatol. (2004) 43(8):608-610.
   PubMed Web of Science ®Google Scholar
• RUBEGNI P, POGGIALI S, SBANO P, RISULO M, FIMIANI M: A case of Darier's disease successfully treated with topical tacrolimus. J. Eur. Acad. Dermatol. Venereol. (2006) 20(1):84-87.
   PubMed Web of Science ®Google Scholar
• TZUNG TY, WU JC: Topical calcineurin inhibitors in treating Jessner's lymphocytic infiltration of the skin: report of a case. Br. J. Dermatol. (2005) 152(2):383-384.
   PubMed Web of Science ®Google Scholar
• MIURA H, ITAMI S, YOSHIKAWA K: Treatment of facial lesion of cutaneous plasmacytosis with tacrolimus ointment. J. Am. Acad. Dermatol. (2003) 49(6):1195-1196.
   PubMed Web of Science ®Google Scholar
• RUBEGNI P, SBANO P, RISULO M, POGGIALI S, FIMIANI M: A case of reticular erythematous mucinosis treated with topical tacrolimus. Br. J. Dermatol. (2004) 150(1):173-174.
   PubMed Web of Science ®Google Scholar
• WERCHNIAK AE, STORM CA, PLUNKETT RW, BEUTNER EH, DINULOS JG: Treatment of pyostomatitis vegetans with topical tacrolimus. J. Am. Acad. Dermatol. (2005) 52(4):722-723.
   PubMed Web of Science ®Google Scholar
• CONNOLLY M, KENNEDY C: Exfoliative cheilitis successfully treated with topical tacrolimus. Br. J. Dermatol. (2004) 151(1):241-242.
   PubMed Web of Science ®Google Scholar
• MASHIKO M, YOKOTA K, YAMANAKA Y, FURUYA K: A case of angiolymphoid hyperplasia with eosinophilia successfully treated with tacrolimus ointment. Br. J. Dermatol. (2006) 154(4):803-804.
   PubMed Web of Science ®Google Scholar
• SUGA Y, TSUBOI R, HASHIMOTO Y, YOSHIIKE T, OGAWA H: A case of ichthyosis linearis circumflexa successfully treated with topical tacrolimus. J. Am. Acad. Dermatol. (2000) 42(3):520-522.
   PubMed Web of Science ®Google Scholar
• VIGLIZZO G, VERRINI A, RONGIOLETTI F: Familial Lassueur-Graham-Little-Piccardi syndrome. Dermatology (2004) 208(2):142-144.
   PubMed Web of Science ®Google Scholar
• BENS G, BORALEVI F, BUZENET C, TAIEB A: Topical treatment of Netherton's syndrome with tacrolimus ointment without significant systemic absorption. Br. J. Dermatol. (2003) 149(1):224-226.
   PubMed Web of Science ®Google Scholar
• RIGOPOULOS D, GREGORIOU S, CHARISSI S, KONTOCHRISTOPOULOS G, KALOGEROMITROS D, GEORGALA S: Tacrolimus ointment 0.1% in pityriasis alba: an open-label, randomized, placebo-controlled study. Br. J. Dermatol. (2006) 155(1):152-155.
   PubMed Web of Science ®Google Scholar
• CORROCHER G, DI LORENZO G, MANSUETO P et al.: Comparison of topical tacrolimus 0.1% in pectin ointment with clobetasol 0.5% ointment in adults with moderate to severe desquamative gingivitis: a 4-week, randomized, double-blind clinical trial. Clin. Ther. (2006) 28(9):1296-1302.
   PubMed Web of Science ®Google Scholar
• CHAPMAN MS, BROWN JM, LINOWSKI GJ: 0.1% tacrolimus ointment for the treatment of intertrigo. Arch. Dermatol. (2005) 141(6):787.
   PubMedGoogle Scholar
• CHOI CJ, NGHIEM P: Tacrolimus ointment in the treatment of chronic cutaneous graft-vs-host disease: a case series of 18 patients. Arch. Dermatol. (2001) 137(9):1202-1206.
   PubMed Web of Science ®Google Scholar
• CASSON DH, ELTUMI M, TOMLIN S, WALKER-SMITH JA, MURCH SH: Topical tacrolimus may be effective in the treatment of oral and perineal Crohn's disease. Gut (2000) 47(3):436-440.
   PubMed Web of Science ®Google Scholar
• SHIPLEY DR, KENNEDY CT: Juvenile plantar dermatosis responding to topical tacrolimus ointment. Clin. Exp. Dermatol. (2006) 31(3):453-454.
   PubMed Web of Science ®Google Scholar
• KUYPERS DR, CLAES K, EVENEPOEL P, MAES B, VANRENTERGHEM Y: A prospective proof of concept study of the efficacy of tacrolimus ointment on uraemic pruritus (UP) in patients on chronic dialysis therapy. Nephrol. Dial. Transplant. (2004) 19(7):1895-1901.
   PubMed Web of Science ®Google Scholar
• DUQUE MI, YOSIPOVITCH G, FLEISCHER AB Jr, WILLARD J, FREEDMAN BI: Lack of efficacy of tacrolimus ointment 0.1% for treatment of hemodialysis-related pruritus: a randomized, double-blind, vehicle-controlled study. J. Am. Acad. Dermatol. (2005) 52(3 Part 1):519-521.
   PubMed Web of Science ®Google Scholar
• AGUILAR-BERNIER M, BASSAS-VILA J, SANZ-MUNOZ C, MIRANDA-ROMERO A: Successful treatment of pruritus with topical tacrolimus in a patient with primary biliary cirrhosis. Br. J. Dermatol. (2005) 152(4):808-809.
   PubMed Web of Science ®Google Scholar
• REITAMO S, RISSANEN J, REMITZ A et al.: Tacrolimus ointment does not affect collagen synthesis: results of a single-center randomized trial. J. Invest. Dermatol. (1998) 111(3):396-398.
   PubMed Web of Science ®Google Scholar
• SHAW DW, EICHENFIELD LF, SHAINHOUSE T, MAIBACH HI: Allergic contact dermatitis from tacrolimus. J. Am. Acad. Dermatol. (2004) 50(6):962-965.
   PubMed Web of Science ®Google Scholar
• ALLEN A, SIEGFRIED E, SILVERMAN R et al.: Significant absorption of topical tacrolimus in 3 patients with Netherton syndrome. Arch. Dermatol. (2001) 137(6):747-750.
   PubMed Web of Science ®Google Scholar
• LONSDALE-ECCLES AA, VELANGI S: Herpes simplex of the vulva evoked by topical tacrolimus treatment. Clin. Exp. Dermatol. (2005) 30(1):95-96.
   PubMed Web of Science ®Google Scholar
• FLEISCHER AB Jr, LING M, EICHENFIELD L et al.: Tacrolimus ointment for the treatment of atopic dermatitis is not associated with an increase in cutaneous infections. J. Am. Acad. Dermatol. (2002) 47(4):562-570.
   PubMed Web of Science ®Google Scholar
• AARONSON DW: The “black box” warning and allergy drugs. J. Allergy Clin. Immunol. (2006) 117:40-44.
   PubMed Web of Science ®Google Scholar
• RING J, BARKER J, BEHRENDT H et al.: Review of the potential photo-cocarcinogenicity of topical calcineurin inhibitors: position statement of the European Dermatology Forum. J. Eur. Acad. Dermatol. Venereol. (2005) 19(6):663-671.
   PubMed Web of Science ®Google Scholar
• BERGER TG, DUVIC M, VAN VOORHEES AS, VANBEEK MJ, FRIEDEN IJ: The use of topical calcineurin inhibitors in dermatology: safety concerns. Report of the American Academy of Dermatology Association Task Force. J. Am. Acad. Dermatol. (2006) 54(5):818-823.
   PubMed Web of Science ®Google Scholar
• FONACIER L, SPERGEL J, CHARLESWORTH EN et al.: Report of the topical calcineurin inhibitor task force of the American college of allergy, asthma and immunology and the American academy of allergy, asthma and immunology. J. Allergy Clin. Immunol. (2005) 115:1249-1253.
   PubMed Web of Science ®Google Scholar
• FLEISCHER A: Black box warning for topical calcineurin inhibitors and the death of common sense. Dermatol. Online J. (2006) 12(6):2.
   PubMedGoogle Scholar
• NAYLOR M, ELMETS C, JARACZ E, RICO JM: Non-melanoma skin cancer in patients with atopic dermatitis treated with topical tacrolimus. J. Dermatolog. Treat. (2005) 16(3):149-153.
   PubMed Web of Science ®Google Scholar
• HULTSCH T, KAPP A, SPERGEL J: Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis. Dermatology (2005) 211:174-187.
   PubMed Web of Science ®Google Scholar
• CARROLL CL, FLEISCHER AB Jr: Tacrolimus: focusing on atopic dermatitis. Drugs Today (Barc.) (2006) 42(7):431-439.
   PubMed Web of Science ®Google Scholar